Axon Enterprise stock eased after an insider sale, even as the company posted strong second-quarter figures. [1] Ad-hoc-news filed both halves of that sentence together. [1] Zacks had already flagged Axon falling harder than the broader market earlier in the week. [2] A ticker is not a verdict, and an insider sale is not a court filing.

The LSU lawsuit sits on the sports page. Axon's share price sits here. The two share a week and a manufacturer of law-enforcement hardware, not a docket. Silence from a court is not a win for either side.

Stock copy tempts every desk into reading prices as judgments. This desk declines. No civil-judgment PDF is in Monday's Axon stack, so the ticker stays a ticker. Insider sales at growth companies routinely follow strong quarters, when executives' options vest into strength. The Q2 figures themselves beat expectations, which is the part of the filing the ticker-watchers skipped.

Declined readings hold; the desk declines. Declining is the update. Tickers stay tickers.

Tickers stay tickers; insider sales followed a beat quarter. Options vest into strength. Courts never convene on charts.

Insider sales followed a beat quarter. Options vest into strength. Courts never convene on charts.

Beat quarters often precede insider sales when grants vest. That sequence explains a softer print better than any lawsuit does. This business file will not borrow a judgment from the sports page. Share prices are not judges.
Monday's chart is not a judgment. Share prices are not judges. Courts never convene on charts.

Monday's chart is not a judgment. Share prices are not judges. Courts never convene on charts.

-- THEO KAPLAN, San Francisco